Good luck on this one also, FATCat. I don't like to hold thru a binary event esp if the chances don't look good. They chose a tough patient population w/ such a low eGFR. Hopefully, there will be a difference between placebo and the galectin grp. I wished they had chosen a higher eGFR group to study. I'm out for now.
News 
Market Data 
Discover 
